UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Multiple Sclerosis: Current Knowledge and Future Outlook

European neurology, 2014-01, Vol.72 (3-4), p.132-141

2014

Volltextzugriff (PDF)

Digital health for chronic disease management: An exploratory method to investigating technology adoption potential

PloS one, 2023-04, Vol.18 (4), p.e0284477-e0284477

2023

Volltextzugriff (PDF)

Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors

Frontiers in neurology, 2021-07, Vol.12, p.693440-693440

2021

Volltextzugriff (PDF)

Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results

Journal of headache and pain, 2022-12, Vol.23 (1), p.161-161, Article 161

2022

Volltextzugriff (PDF)

Role of Family Planning in Women With Multiple Sclerosis in Switzerland: Results of the Women With Multiple Sclerosis Patient Survey

Frontiers in neurology, 2018-10, Vol.9, p.821-821

2018

Volltextzugriff (PDF)

60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments

Frontiers in neurology, 2020-03, Vol.11, p.156-156

2020

Volltextzugriff (PDF)

A Framework for Estimating the Burden of Chronic Diseases: Design and Application in the Context of Multiple Sclerosis

Frontiers in neurology, 2019-09, Vol.10, p.953-953

2019

Volltextzugriff (PDF)

Limb Apraxia in Multiple Sclerosis: Prevalence and Impact on Manual Dexterity and Activities of Daily Living

Archives of physical medicine and rehabilitation, 2012-06, Vol.93 (6), p.1081-1085

2012

Volltextzugriff (PDF)

Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial

PloS one, 2014-01, Vol.9 (1), p.e86663-e86663

2014

Volltextzugriff (PDF)

Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients

Vaccines (Basel), 2022-06, Vol.10 (6), p.922

2022

Volltextzugriff (PDF)

Tablet App Based Dexterity Training in Multiple Sclerosis (TAD-MS): Research Protocol of a Randomized Controlled Trial

Frontiers in neurology, 2019-02, Vol.10, p.61

2019

Volltextzugriff (PDF)

Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?

CNS neuroscience & therapeutics, 2022-06, Vol.28 (6), p.971-973

2022

Volltextzugriff (PDF)

Behavioral Changes in Patients with Multiple Sclerosis

Frontiers in neurology, 2017-08, Vol.8, p.437-437

2017

Volltextzugriff (PDF)

Relationship between Job Demands‐Resources and turnover intention in chronic disease – The example of multiple sclerosis

Stress and health, 2021-12, Vol.37 (5), p.940-948

2021

Volltextzugriff (PDF)

Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease

Swiss medical weekly, 2013-05, Vol.143, p.w13783

2013

Volltextzugriff (PDF)

Video-Based Pairwise Comparison: Enabling the Development of Automated Rating of Motor Dysfunction in Multiple Sclerosis

Archives of physical medicine and rehabilitation, 2020-02, Vol.101 (2), p.234-241

2020

Volltextzugriff (PDF)

Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?

Journal of psychosomatic research, 2021-05, Vol.144, p.110402-110402, Article 110402

2021

Volltextzugriff (PDF)

Hypomagnesemia-Induced Cerebellar Syndrome—A Distinct Disease Entity? Case Report and Literature Review

Frontiers in neurology, 2020-09, Vol.11

2020

Volltextzugriff (PDF)

Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries

Multiple sclerosis, 2021-01, Vol.27 (1), p.90-96

2021

Volltextzugriff (PDF)

How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis

Multiple sclerosis, 2020-04, Vol.26 (4), p.489-500

2020

Volltextzugriff (PDF)

SWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology

Trials, 2009-12, Vol.10 (1), p.115-115, Article 115

2009

Volltextzugriff (PDF)

Age‐dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross‐sectional study

CNS neuroscience & therapeutics, 2019-04, Vol.25 (4), p.527-531

2019

Volltextzugriff (PDF)

T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter

Scientific reports, 2018-11, Vol.8 (1), p.16844-8, Article 16844

2018

Volltextzugriff (PDF)

Factors associated with material deprivation in persons with multiple sclerosis in Switzerland: Cross-sectional data from the Swiss Multiple Sclerosis Registry

Multiple sclerosis and related disorders, 2023-01, Vol.69, p.104438-104438, Article 104438

2023

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Aktive Filter

ThemaQuality Of Life

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Englisch
(66)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multiple Sclerosis: Current Knowledge and Future Outlook

Digital health for chronic disease management: An exploratory method to investigating technology adoption potential

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options

Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors

Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results

Role of Family Planning in Women With Multiple Sclerosis in Switzerland: Results of the Women With Multiple Sclerosis Patient Survey

60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments

A Framework for Estimating the Burden of Chronic Diseases: Design and Application in the Context of Multiple Sclerosis

Limb Apraxia in Multiple Sclerosis: Prevalence and Impact on Manual Dexterity and Activities of Daily Living

Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial

Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients

Tablet App Based Dexterity Training in Multiple Sclerosis (TAD-MS): Research Protocol of a Randomized Controlled Trial

Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?

Behavioral Changes in Patients with Multiple Sclerosis

Relationship between Job Demands‐Resources and turnover intention in chronic disease – The example of multiple sclerosis

Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease

Video-Based Pairwise Comparison: Enabling the Development of Automated Rating of Motor Dysfunction in Multiple Sclerosis

Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?

Hypomagnesemia-Induced Cerebellar Syndrome—A Distinct Disease Entity? Case Report and Literature Review

Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries

How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis

SWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology

Age‐dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross‐sectional study

T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter

Factors associated with material deprivation in persons with multiple sclerosis in Switzerland: Cross-sectional data from the Swiss Multiple Sclerosis Registry

Aktive Filter

Suchergebnisse filtern